Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Diabetes
Interventions
DEVICE

Subcutaneous delivery via Medtronic Quick-Set

Infusion rates and pre-meal bolus doses will be based on subjects known daily infusion rate and subject's reported insulin to carbohydrate ratio.

DEVICE

Intradermal delivery via the BD Research Catheter Set

Infusion rates and pre-meal bolus doses will be based on subjects known daily infusion rate and subject's reported insulin to carbohydrate ratio.

Trial Locations (1)

D-41460

Profil Institut fur Stoffwechselfforschung GmbH, Neuss

Sponsors
All Listed Sponsors
lead

Becton, Dickinson and Company

INDUSTRY